Hikal Limited (BOM:524735)

Market Cap	43.53B
Revenue (ttm)	18.60B
Net Income (ttm)	908.00M
Shares Out	123.30M
EPS (ttm)	7.36
PE Ratio	47.96
Forward PE	31.24
Dividend	1.60 (0.46%)
Ex-Dividend Date	Feb 7, 2025

Volume	17,739
Average Volume	22,456
Open	345.45
Previous Close	345.45
Day's Range	341.00 - 349.65
52-Week Range	309.45 - 464.50
Beta	0.59
RSI	47.33
Earnings Date	Aug 5, 2025

About Hikal

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, wh...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 2,061
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524735

Financial Performance

In 2024, Hikal's revenue was 18.60 billion, an increase of 4.21% compared to the previous year's 17.85 billion. Earnings were 908.00 million, an increase of 30.46%.